Clinical Trial Update: Safety Study of Tipranavir Co-administered With Low-dose Ritonavir (TPV/r) in Patients With Advanced HIV-1 Infection and Limited Treatment Options [Phase 3]

View source ↗

Summary

Phase 3 safety study assessing tipranavir co-administered with low-dose ritonavir in adults with advanced HIV-1 infection and limited treatment options; the tri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Aptivus (tipranavir)
• Norvir (ritonavir)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: HIV Infections | Phase 3 | Status: COMPLETED